Relenza Powder
Product Images NDC 0173-0681

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Relenza (NDC 0173-0681). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Glaxosmithkline Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Zanamivir Structural Formula (Relenza Spl Graphic 01)

Zanamivir Structural Formula (Relenza Spl Graphic 01)
FDA Label Image

Relenza Logo (Relenza Spl Graphic 02)

Relenza Logo (Relenza Spl Graphic 02)
This text is a description of how to use the DISKHALER device to inhale medication. It includes information on keeping the device clean, the purpose of the mouthpiece, how to advance to the next dose, how to release the medication, and the components of the device.*
FDA Label Image

Parts Of The Diskhaler (Relenza Spl Graphic 03)

Parts Of The Diskhaler (Relenza Spl Graphic 03)
FDA Label Image

Step A: Load The Medicine In Diskhaler (Relenza Spl Graphic 04)

Step A: Load The Medicine In Diskhaler (Relenza Spl Graphic 04)
FDA Label Image

Step B: Steps 1, 2, 3, And 4 (Relenza Spl Graphic 05)

Step B: Steps 1, 2, 3, And 4 (Relenza Spl Graphic 05)
FDA Label Image

Step C: Steps 1 And 2 (Relenza Spl Graphic 06)

Step C: Steps 1 And 2 (Relenza Spl Graphic 06)
FDA Label Image

Step D: Steps 1 And 2 (Relenza Spl Graphic 07)

Step D: Steps 1 And 2 (Relenza Spl Graphic 07)
FDA Label Image

Relenza Carton (Relenza Spl Graphic 08)

Relenza Carton (Relenza Spl Graphic 08)
FDA Label Image

Relenza Spl Graphic 09

Relenza Spl Graphic 09
FDA Label Image

Relenza Spl Graphic 10

Relenza Spl Graphic 10
FDA Label Image

Relenza Spl Graphic 11

Relenza Spl Graphic 11
FDA Label Image

Relenza Spl Graphic 12

Relenza Spl Graphic 12
FDA Label Image

Relenza Spl Graphic 13

Relenza Spl Graphic 13
FDA Label Image

Relenza Spl Graphic 14

Relenza Spl Graphic 14
FDA Label Image

Relenza Spl Graphic 15

Relenza Spl Graphic 15
This is a description of a medication called RELENZA, with NDC code 0173-0681-01, which is an inhalation powder containing 20mg of zanamivir. Each blister contains 5mg of zanamivir along with lactose. The medication should be used with the DISKHALER inhalation device only, and there are patient information and instructions enclosed for its use. The medication must be stored at a temperature between 15° to 30°C (59° to 86°F). It contains 5 RELANZA ROTADISKS, each with 4 blisters containing 5mg zanamivir, and one DISKHALER inhalation device. The dosage information should be obtained from the prescribing information. This medication is intended for oral inhalation only.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.